Joel C Bronstein
Affiliation: Pfizer Global Research and Development
- 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organismsEdmund L Ellsworth
Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
J Med Chem 49:6435-8. 2006..These agents also demonstrate in vivo efficacy in murine systemic infection models...
- Purification and characterization of recombinant Staphylococcus haemolyticus DNA gyrase and topoisomerase IV expressed in Escherichia coliJoel C Bronstein
Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
Antimicrob Agents Chemother 48:2708-11. 2004..This represents the first description of a method for isolating type II topoisomerases of a coagulase-negative staphylococcal species...